NO20073574L - Triazolsubstituerte aminobenzofenonforbindelser - Google Patents

Triazolsubstituerte aminobenzofenonforbindelser

Info

Publication number: NO20073574L
Authority: NO; Norway
Prior art keywords: triazole; aminobenzophenone compounds; compounds; substituted aminobenzophenone; substituted
Prior art date: 2004-12-13

Application number

NO20073574A

Other languages

English (en)

Norwegian (no)

Inventor

Erik Rytter Ottosen

Original Assignee

Leo Pharma As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-13

Filing date

2007-07-10

Publication date

2007-07-10

2007-07-10 Application filed by Leo Pharma As filed Critical Leo Pharma As

2007-07-10 Publication of NO20073574L publication Critical patent/NO20073574L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20073574A 2004-12-13 2007-07-10 Triazolsubstituerte aminobenzofenonforbindelser NO20073574L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US63500004P	2004-12-13	2004-12-13
DKPA200401942		2004-12-16
PCT/DK2005/000757 WO2006063585A1 (en)	2004-12-13	2005-11-28	Triazole substituted aminobenzophenone compounds

Publications (1)

Publication Number	Publication Date
NO20073574L true NO20073574L (no)	2007-07-10

Family

ID=37715934

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20073574A NO20073574L (no)	2004-12-13	2007-07-10	Triazolsubstituerte aminobenzofenonforbindelser

Country Status (23)

Country	Link
US (1)	US8293772B2 (de)
EP (1)	EP1828148B1 (de)
JP (1)	JP5015005B2 (de)
KR (1)	KR101260236B1 (de)
CN (1)	CN101115728B (de)
AR (1)	AR051792A1 (de)
AT (1)	ATE455768T1 (de)
AU (1)	AU2005316034B2 (de)
BR (1)	BRPI0518993A2 (de)
CA (1)	CA2590479A1 (de)
DE (1)	DE602005019093D1 (de)
DK (1)	DK1828148T3 (de)
ES (1)	ES2341473T3 (de)
HR (1)	HRP20100225T1 (de)
IL (1)	IL183513A0 (de)
MX (1)	MX2007006739A (de)
NO (1)	NO20073574L (de)
PL (1)	PL1828148T3 (de)
PT (1)	PT1828148E (de)
RU (1)	RU2394818C2 (de)
UA (1)	UA90698C2 (de)
WO (1)	WO2006063585A1 (de)
ZA (1)	ZA200704809B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1671673B (zh)	2002-05-30	2010-05-26	斯克里普斯研究学院	铜催化的叠氮化物和乙炔的连接
WO2007148074A1 (en) *	2006-06-21	2007-12-27	Hammersmith Imanet Limited	Chemical methods and apparatus
US8080540B2 (en)	2006-09-19	2011-12-20	Abbott Products Gmbh	Therapeutically active triazoles and their use
KR100932093B1 (ko)	2006-09-27	2009-12-16	주식회사종근당	미세소관 형성 저해제로서 유용한 벤조페논 유도체
US8288367B2 (en)	2006-11-30	2012-10-16	Solvay Pharmaceuticals Gmbh	Substituted estratriene derivatives as 17BETA HSD inhibitors
MX2010006241A (es) *	2007-12-18	2010-06-30	Actelion Pharmaceuticals Ltd	Derivados de aminotriazol como agonistas de alx.
ES2536794T3 (es) *	2008-03-26	2015-05-28	Chong Kun Dang Pharmaceutical Corp.	Derivados de benzofenona tiazol útiles para inhibir la formación de microtúbulos y método de producción de los mismos
US8822513B2 (en)	2010-03-01	2014-09-02	Gtx, Inc.	Compounds for treatment of cancer
US9029408B2 (en)	2008-06-16	2015-05-12	Gtx, Inc.	Compounds for treatment of cancer
US9447049B2 (en)	2010-03-01	2016-09-20	University Of Tennessee Research Foundation	Compounds for treatment of cancer
EP3289876B1 (de)	2008-06-16	2022-07-20	University of Tennessee Research Foundation	Verbindungen zur krebsbehandlung
AU2010335654B2 (en)	2009-12-22	2015-04-09	Leo Pharma A/S	Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
CA2785253A1 (en)	2009-12-22	2011-06-30	Leo Pharma A/S	Calcipotriol monohydrate nanocrystals
MX2012007225A (es)	2009-12-22	2012-07-30	Leo Pharma As	Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
AU2010347233B2 (en)	2010-03-01	2015-06-18	Oncternal Therapeutics, Inc.	Compounds for treatment of cancer
US8912184B1 (en)	2010-03-01	2014-12-16	Alzheimer's Institute Of America, Inc.	Therapeutic and diagnostic methods
KR101666759B1 (ko) *	2015-08-06	2016-10-18	경북대학교 산학협력단	1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도
CN106632285B (zh) *	2016-11-23	2019-11-01	河南师范大学	一种齐多夫定-1,2,3-三氮唑类化合物的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9701453D0 (en) *	1997-01-24	1997-03-12	Leo Pharm Prod Ltd	Aminobenzophenones
AU769138B2 (en)	1999-07-16	2004-01-15	Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)	Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
EP1210325B1 (de)	1999-07-16	2004-10-06	Leo Pharma A/S	Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
WO2001005744A1 (en)	1999-07-16	2001-01-25	Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab)	Novel aminobenzophenones
ATE277897T1 (de)	1999-07-16	2004-10-15	Leo Pharma As	Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
DK1202957T3 (da)	1999-07-16	2005-01-31	Leo Pharma As	Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
DE60034961T2 (de) *	1999-12-06	2008-01-24	Leo Pharma A/S	Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
CN1239485C (zh)	2000-05-22	2006-02-01	里奥制药有限公司	作为IL－1β和TNF－α抑制剂的二苯酮类
GB0107368D0 (en) *	2001-03-23	2001-05-16	Novartis Ag	Organic compounds
US20030073832A1 (en)	2001-04-10	2003-04-17	Havez Sophie Elisabeth	Novel aminophenyl ketone derivatives
KR100896667B1 (ko)	2001-08-28	2009-05-14	레오 파마 에이/에스	신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물
AR042634A1 (es)	2002-12-20	2005-06-29	Leo Pharma As	Compuestos de aminobenzofenona
ATE469878T1 (de) *	2003-07-24	2010-06-15	Leo Pharma As	Aminobenzophenonverbindungen
US20090313239A1 (en)	2008-06-16	2009-12-17	Microsoft Corporation	Adaptive Visual Similarity for Text-Based Image Search Results Re-ranking

2005
- 2005-11-28 DK DK05804019.7T patent/DK1828148T3/da active
- 2005-11-28 RU RU2007126648/04A patent/RU2394818C2/ru not_active IP Right Cessation
- 2005-11-28 CN CN2005800480385A patent/CN101115728B/zh not_active Expired - Fee Related
- 2005-11-28 DE DE602005019093T patent/DE602005019093D1/de active Active
- 2005-11-28 EP EP05804019A patent/EP1828148B1/de active Active
- 2005-11-28 UA UAA200707890A patent/UA90698C2/ru unknown
- 2005-11-28 AU AU2005316034A patent/AU2005316034B2/en not_active Ceased
- 2005-11-28 ES ES05804019T patent/ES2341473T3/es active Active
- 2005-11-28 ZA ZA200704809A patent/ZA200704809B/xx unknown
- 2005-11-28 PL PL05804019T patent/PL1828148T3/pl unknown
- 2005-11-28 MX MX2007006739A patent/MX2007006739A/es active IP Right Grant
- 2005-11-28 BR BRPI0518993-4A patent/BRPI0518993A2/pt not_active IP Right Cessation
- 2005-11-28 JP JP2007545836A patent/JP5015005B2/ja not_active Expired - Fee Related
- 2005-11-28 CA CA002590479A patent/CA2590479A1/en not_active Abandoned
- 2005-11-28 AT AT05804019T patent/ATE455768T1/de active
- 2005-11-28 KR KR1020077015959A patent/KR101260236B1/ko not_active IP Right Cessation
- 2005-11-28 WO PCT/DK2005/000757 patent/WO2006063585A1/en active Application Filing
- 2005-11-28 PT PT05804019T patent/PT1828148E/pt unknown
- 2005-12-02 US US11/292,064 patent/US8293772B2/en not_active Expired - Fee Related
- 2005-12-12 AR ARP050105193A patent/AR051792A1/es not_active Application Discontinuation
2007
- 2007-05-29 IL IL183513A patent/IL183513A0/en unknown
- 2007-07-10 NO NO20073574A patent/NO20073574L/no not_active Application Discontinuation
2010
- 2010-04-19 HR HR20100225T patent/HRP20100225T1/hr unknown

Also Published As

Publication number	Publication date
PL1828148T3 (pl)	2010-08-31
CN101115728A (zh)	2008-01-30
MX2007006739A (es)	2007-08-02
RU2394818C2 (ru)	2010-07-20
US8293772B2 (en)	2012-10-23
CA2590479A1 (en)	2006-06-22
WO2006063585A1 (en)	2006-06-22
KR20070095945A (ko)	2007-10-01
IL183513A0 (en)	2007-09-20
DK1828148T3 (da)	2010-05-17
JP5015005B2 (ja)	2012-08-29
AU2005316034B2 (en)	2012-01-19
ZA200704809B (en)	2008-08-27
ES2341473T3 (es)	2010-06-21
EP1828148A1 (de)	2007-09-05
US20060128766A1 (en)	2006-06-15
RU2007126648A (ru)	2009-01-20
HRP20100225T1 (hr)	2010-07-31
PT1828148E (pt)	2010-05-04
JP2008523115A (ja)	2008-07-03
CN101115728B (zh)	2012-12-19
BRPI0518993A2 (pt)	2008-12-23
UA90698C2 (en)	2010-05-25
KR101260236B1 (ko)	2013-05-06
ATE455768T1 (de)	2010-02-15
DE602005019093D1 (de)	2010-03-11
AR051792A1 (es)	2007-02-07
AU2005316034A1 (en)	2006-06-22
EP1828148B1 (de)	2010-01-20

Publication	Publication Date	Title
NO20073574L (no)	2007-07-10	Triazolsubstituerte aminobenzofenonforbindelser
NO20060230L (no)	2006-01-16	Nye aminobenzofenonforbindelser
NO20082594L (no)	2008-06-10	Pyrimidinylbenzotiofenforbindelser
ATE448232T1 (de)	2009-11-15	Substituierte heterozyklen
CY1116754T1 (el)	2017-03-15	Παραγωγα νιτροκατεχολης ως αναστολεις της comt
NO20092639L (no)	2009-09-11	4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
NO20055516L (no)	2005-11-22	Kannabinoidreceptorligander og anvendelser derav
TW200714590A (en)	2007-04-16	Heterocyclic inhibitors of MEK and methods of use thereof
EA200802213A1 (ru)	2009-10-30	Способы лечения заболеваний крови
EA200700175A1 (ru)	2007-08-31	Композиции и способы лечения воспалительных заболеваний
NO20062020L (no)	2006-07-10	1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
CY1106476T1 (el)	2012-01-25	Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
NO20055731L (no)	2006-02-06	Cannabinoide reseptorligander og deres anvendelse
NO20053792L (no)	2005-08-10	Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander
CR8696A (es)	2007-08-28	Beta-carbolinas utiles para tratar enfermedades inflamatorias
NO20055741L (no)	2006-01-06	Nye kjemiske forbindelser
ECSP055844A (es)	2005-09-20	Nuevos compuestos triciclicos
NO20055563L (no)	2005-11-24	Midler for behandlingen av lavere abdominale lidelser
SE0300457D0 (sv)	2003-02-19	Novel compounds
ATE496047T1 (de)	2011-02-15	Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien
DE502005005652D1 (de)	2008-11-20	Heterocyclyl-substituierte nonadepsipeptide
DE502005008925D1 (de)	2010-03-11	Substituierte nonadepsipeptide
DK1904511T3 (da)	2009-10-12	Homogemcitabin
ATE553088T1 (de)	2012-04-15	Substituierte chinolone ii
WO2005080549A3 (de)	2005-12-08	Trioxacarcine und deren verwendung gegen infektionskrankheiten

Legal Events

Date	Code	Title	Description
2009-02-09	RE	Reestablishment of rights (par. 72 patents act)
2017-07-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application